Influence of prepartum body condition score change on reproduction in multiparous beef cows calving in moderate body condition.

Multiparous, spring-calving beef cows (n = 250) were used to determine whether large changes in body energy reserves during mid- to late gestation influenced subsequent reproductive performance of cows calving in moderate body condition. In three states, cows were blocked by BW and body condition score (BCS; 1 = emaciated to 9 = obese) then allotted to receive either a high or low plane of nutrition from late summer to early winter over a 3-yr period. This generated an array of BCS by the beginning of the last trimester of pregnancy when cows were grouped by BCS as follows: Group 1, BCS < or = 4; Group 2, BCS of 5 or 6; and Group 3, BCS > or = 7. Each group was managed so that individual cows would calve with a BCS of 5 to 6. At the time of group assignment, mean BW and BCS differed (P < .01) among groups and were 480 kg and 3.6, 541 kg and 5.5, and 594 kg and 7.1 for Groups 1 to 3, respectively. Within 28 d before calving, BW and BCS were similar (P > .20) among groups averaging 555 kg and 5.1. Prepartum BCS changes averaged 1.4, -.4, and -2.0 units for Groups 1 to 3, respectively (P < .01). Cows were managed as a single group after calving in each state. Location effect was significant for the prepartum and postpartum BW and BCS changes but not for postpartum reproductive performance. Significant location x BCS group interactions were found for the 90-d prepartum BW, BCS at calving, and prepartum changes in BW, but were caused by differences in magnitude among locations. The percentage of cows with luteal activity at the start of a subsequent breeding season was not affected (P > .20) by either location or BCS group, and averaged 66%. Mean pregnancy rates at 20, 40, and 60 d of a subsequent breeding season were 55, 76, and 89% for Group 1; 51, 67, and 82% for Group 2; and 64, 79, and 89% for Group 3 (P > .30). Mean days to conception were 89, 87, and 85 for Groups 1 to 3, respectively (P = .70). Neither calf birth weight (x = 38.6 kg) nor adjusted 205-d weight (x = 223.6 kg) were affected by prepartum BW and BCS changes. We conclude that reproductive performance of cows calving in moderate body condition is not influenced by large changes in body energy reserves during the last trimester of pregnancy.

Intraoperative ultrasound localization of nonpalpable breast lesions.

BACKGROUND: The use of preoperative wire localization (PWL) for excision of nonpalpable breast lesions has several disadvantages. The purpose of this study was to evaluate the use of intraoperative ultrasound localization (IUL) and to compare it with PWL. METHODS: Twenty-nine patients (22 with cancer) underwent IUL in a solo surgical practice over a 21-month period. They were compared to 22 patients with cancer in the same practice who underwent PWL in a similar time period. Parameters analyzed included accuracy of lesion removal, margin involvement, extent of disease-free margin, and the amount of tissue removed. RESULTS: The targeted lesions were accurately removed 100% of the time, and disease-free margins were obtained at the first operation in 82% of patients in both groups. An equivalent amount of disease-free margin (IUL, 6.6 mm; PWL, 6.7 mm) was obtained with IUL while removing a smaller (IUL, 62.6 cm3; PWL, 81.1 cm3) mean volume of tissue. CONCLUSIONS: IUL is an accurate method of localizing most nonpalpable mass lesions identified on mammography. Equivalent margin status can be achieved while removing no more tissue than with PWL. The trauma of wire localization in an awake patient is avoided.

Influence of permethrin, diazinon and ivermectin treatments on insecticide resistance in the horn fly (Diptera: Muscidae).

The history of insecticide resistance in the horn fly, Haematobia irritans, and the relationship between the characteristics of horn fly biology and insecticide use on resistance development is discussed. Colonies of susceptible horn flies were selected for resistance with six insecticide treatment regimens: continuous single use of permethrin, diazinon and ivermectin: permethrin-diazinon (1:2) mixture; and permethrin-diazinon and permethrin-ivermectin rotation (4-month cycle). Under laboratory conditions, resistance developed during generations 21, 31 and 30 to permethrin, diazinon and ivermectin, respectively. The magnitude of resistance ranged from < 3-fold with ivermectin to 1470-fold with permethrin. Field studies demonstrated that use of a single class of insecticidal ear tag during the horn-fly season resulted in product failure within 3-4 years for pyrethroids and organophosphates, respectively. In laboratory studies, use of alternating insecticides or a mixture of insecticides delayed the onset of resistance for up to 12 generations and reduced the magnitude of pyrethroid resistance. In field studies, yearly alternated use of pyrethroids and organophosphates did not slow or reverse pyrethroid resistance (Barros et al., unpublished data), while a 2-year alternated use with organophosphates resulted in partial reversion of pyrethroid resistance. When pyrethroid and organophosphate ear tags were used in a mosaic strategy at two different locations, efficacy of products did not change during a 3-year period.

Body condition at parturition and postpartum weight gain influence luteal activity and concentrations of glucose, insulin, and nonesterified fatty acids in plasma of primiparous beef cows.

Effects of body condition score (BCS) at parturition and postpartum weight gain on luteal activity and concentrations of glucose, insulin, and NEFA in plasma were evaluated during the breeding season in 242 primiparous beef cows over 3 yr (Y) at three locations (L). At approximately 90 d prepartum, cows were blocked by breed, expected calving date, and BCS and randomly assigned to diets so that cows would calve in BCS of 4, 5, or 6. At calving, cows were blocked by breed, calving date, and BCS and randomly allotted to gain .45 (M) or .90 (H) kg/d, from parturition to the start of breeding (postpartum nutrition; PPN). During the 60-d breeding season, weekly blood samples were obtained from cows, and progesterone, insulin, glucose, and NEFA were quantified. Progesterone concentrations greater than 1 ng/mL for more than 1 wk indicated luteal activity. To determine the possible value of blood constituents as predictors of luteal activity, categorical data analyses were performed. Cows with greater BCS at parturition had greater concentrations of glucose during breeding (P < .07). Similarly, PPN influenced glucose at the beginning of breeding, but the differences were minimal after d 28 (PPN x day; P <.001). Cows with greater BCS at parturition and M-PPN had greater concentrations of insulin during the breeding season (BCS x PPN; P < .02). Cows with a BCS of 6 at parturition had the lowest concentrations of NEFA; however, cows on H-PPN had greater concentrations of NEFA (BCS x PPN; P < .03). Location, BCS, PPN, and day affected luteal activity (P < .002). Location differences in luteal activity were associated with the interval from calving to the start of breeding. In general, a greater percentage of cows with BCS of 5 or 6 at calving had luteal activity by the end of the breeding season. Concentrations of metabolites in blood during breeding were not predictive of luteal activity. We conclude that BCS at parturition and postpartum nutrition influence concentrations of glucose, insulin, and NEFA in blood and the onset of luteal activity in primiparous beef cows.

Chemoprevention for colorectal carcinoma.

The literature on chemoprevention for colorectal carcinoma can be summarized as follows: (1) Aspirin and NSAIDs usage can decrease polyp formation and promote polyp regression and have a strong epidemiologic link to colorectal cancer prevention. (2) Fiber intake is strongly associated with a decreased incidence of colorectal carcinoma. Whether supplemental fiber can prevent colorectal neoplasia is not yet clear. (3) Calcium and vitamin D intake is inversely proportional to the risk of developing colorectal carcinoma. Prospective trials make the role of supplemental calcium as a chemoprotective agent unclear: (4) Chemoprevention is an exciting area of research. More work needs to be done to establish the precise steps necessary for neoplastic transformation of cells so that pharmaceuticals can be developed to target carcinogenesis at several levels.

Immunoautoradiographic and in situ hybridization analysis of corticotropin-releasing hormone biosynthesis in the hypothalamic paraventricular nucleus.

Corticotropin-releasing hormone (CRH) gene transcription and mRNA expression are keyed to stimuli activating the pituitary-adrenocortical axis, suggesting a connection between neuronal activation and synthesis of active peptide. However, the relationship between CRH mRNA and levels of CRH peptide remains to be definitively established. The present report characterizes an immunoautoradiographic (IAR) strategy to assess CRH peptide expression in an anatomical context. Non-fixed tissue sections through the rat hypothalamus were reacted with a primary antibody against rat CRH, followed by incubation with [35S] or [125I] labeled secondary antibody. Autoradiography performed on reacted sections revealed that CRH immunoreactivity could be detected in CRH-containing regions of the hypothalamus and amygdala. Generation of CRH signal was blocked by preabsorption of primary antibody with CRH peptide, demonstrating antibody specificity. IAR performed on nitrocellulose blotted with synthetic CRH peptide revealed a linear relationship between peptide quantity and intensity of autoradiographic signal, verifying that this method is appropriate for semi-quantitative analysis of CRH peptide regulation. Assessment of CRH peptide regulation revealed a significant increase in CRH content in adrenalectomized rats (ADX) relative to sham-adrenalectomized (SHAM) controls (196%). In situ hybridization performed on adjacent sections revealed a similar increase in CRH mRNA expression in ADX rats (256%), and a significant correlation between CRH peptide and mRNA measures (r = 0.68). No ADX induced changes were seen in median eminence, dorsomedial hypothalamus or central amygdaloid nucleus. The results of this study indicate that CRH biosynthesis appears to be driven by amount of available mRNA, rather than changes in translational efficacy. In addition, the IAR technique appears ideally suited to allow concomitant assessment of mRNA and protein expression within defined populations of CNS neurons.

Galanin gene expression in radiothyroidectomy-induced thyrotroph adenomas.

Galanin gene expression is markedly increased in the anterior pituitary glands of estrogen-treated rats (lactotroph hyperplasia) as well as human growth hormone-releasing hormone transgenic mice (somatotroph hyperplasia). The objective of this study was to examine galanin in a mouse model of thyrotroph adenoma formation. Male mice were radiothyroidectomized by use of iodine-131 (131I), and galanin peptide levels were assessed in the hypothalamic-pituitary axis. Immunoreactive galanin concentrations in the anterior pituitaries of 131I-treated mice were decreased 80% at 3, 6, 9, and 12 mo after radiothyroidectomy. Galanin peptide levels in the hypothalamus were decreased 20-25% at these times. Treatment with either estradiol or 3,3',5-triiodo-L-thyronine increased galanin peptide concentrations in the anterior pituitaries of 131I-treated mice, but neither treatment restored galanin concentrations. Galanin mRNA levels were decreased > 80% 1 yr after radiothyroidectomy. We conclude that, unlike animal models of lactotroph and somatotroph hyperplasia, galanin gene expression is suppressed throughout the development of thyrotroph adenomas, suggesting that galanin does not have a stimulatory role in the proliferation of thyrotrophs. Moreover, these data show that thyroid hormones are important positive regulators of galanin gene expression in the mouse and that estrogen may stimulate galanin gene expression in the absence of thyroid hormones.

Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.

We recently reported that galanin gene expression is markedly increased in the hyperplastic anterior pituitary gland of the human growth hormone-releasing hormone (hGHRH) transgenic mouse. To determine if another pituitary peptide hormone with putative growth-promoting activity is similarly affected, or if this effect is specific to the peptide galanin, we examined vasoactive intestinal polypeptide (VIP) gene expression in the hypothalamic-pituitary axis of male hGHRH transgenic and non-transgenic mice. The objectives were to: 1) assess VIP peptide concentrations, 2) estimate relative differences in VIP mRNA levels, 3) determine the effects of acute treatment with 17beta-estradiol on VIP peptide and mRNA levels, and 4) quantify the density of immunoreactive VIP pituitary cells by immunohistochemistry. Four to five month old male hGHRH transgenic mice and their non-transgenic siblings were identified by PCR. Immunoreactive VIP concentrations were decreased by 50% in the anterior pituitary glands of hGHRH transgenic mice as compared to non-transgenic siblings. In contrast, no differences in immunoreactive VIP concentrations were observed in the hypothalamus or frontal cerebral cortex of transgenic and non-transgenic mice. Treatment with 17beta-estradiol significantly increased VIP concentrations in the anterior pituitary gland of both transgenic and non-transgenic mice; however, VIP peptide concentrations in the anterior pituitary glands of hGHRH transgenic mice remained 50% lower. Relative differences in VIP mRNA levels were estimated by RT-PCR, and were found to be 2.5-fold higher in the anterior pituitary glands of non-transgenic mice. In contrast, no differences in VIP mRNA levels in the cerebral cortex were detected between transgenic and non-transgenic mice. Treatment with 17beta-estradiol increased VIP mRNA levels in the anterior pituitary, but not in the cerebral cortex. In concert with the changes in VIP peptide and mRNA, the density of immunoreactive VIP pituitary cells was decreased approximately 50% in hGHRH transgenic mice. In conclusion, unlike galanin gene expression, VIP peptide and mRNA levels are significantly decreased in the anterior pituitary gland of hGHRH transgenic mice. Moreover, these changes appear to be tissue-specific and are likely due, in part, to the decrease in the density of VIP-containing pituitary cells in the hyperplastic pituitary. Although the pituitary cell type(s) synthesizing VIP remains unclear, these data suggest that VIP in the anterior pituitary is not stimulating pituitary tumor development in hGHRH transgenic mice.

Reproductive responses and calf birth and weaning weights as affected by body condition at parturition and postpartum weight gain in primiparous beef cows.

Effects of body condition score (BCS) at parturition and postpartum weight gain on reproduction and production responses were evaluated using 240 primiparous (21 to 28 mo) beef cows calving in 60-d periods in three states over 3 yr. Cows were randomly allotted 90 d before parturition and fed to achieve BCS of 4, 5, or 6 (1 = emaciated, 9 = obese) at parturition. After parturition, one-half of these cows (within state) were group-fed to gain .45 kg/d (moderate) or .90 kg/d (high) until the start of a 60-d breeding season. Cows calving in BCS of 4, 5, or 6, respectively, had calves with progressively heavier (P < .05) birth weights, but dystocia score was not influenced by BCS at calving. Parturient BCS of cows had no effect on actual or 205-d adjusted weaning weights of calves. Birth weights, dystocia score, and actual and 205-d adjusted weaning weights were affected by location (P < .05). Cows with greater weight gains postpartum had calves with heavier (P < .05) actual and 205-d adjusted weaning weights than did cows with moderate weight gains. No significant interactions among location, BCS, or postpartum nutrition-group were observed for any of the production variables described above. Greater BCS at calving resulted in more (P < .05) cows in estrus and more (P < .05) cows pregnant by 40 and 60 d of a breeding season. Luteal activity by start of breeding, as well as estrus responses and pregnancy rates at 20, 40, or 60 d of a breeding season, were affected by location (P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of horn fly (Diptera: Muscidae) control during the spring on calf production by fall-calving beef cows.

In the spring of three consecutive years, horn fly, Haematobia irritans (L.), populations on fall-calving cows were reduced 82% for a 12-wk period using pyrethroid-impregnated ear tags. Horn fly populations on control cows exceeded 200 flies per animal for an average of 6 wk. Although the weights of cows and calves and body condition scores of both control and treated groups varied from year to year, a year x treatment effect (P < 0.01) on cow and calf weight gain was observed. However, differences in cow and calf production between treatments were not associated with differences in exposure to horn flies, and no significant effect on weaning weight of fall-born calves was associated with horn fly control. Calf body condition scores were also unaffected by horn fly control.

Prepartum body condition and weight influences on reproductive performance of first-calf beef cows.

Data were collected on 476 spring-calving, primiparous cows at six locations in Louisiana over a 2-yr period. Objectives of the study were to evaluate changes in prepartum body condition score (BCS) and BW of heifers when fed varying energy levels and to determine the influences of prepartum BCS and BW changes and BCS at calving on postpartum traits. Heifers were allocated to one of three energy levels from approximately 90 d prepartum to parturition. The diets were formulated to provide low, recommended, and high energy levels based on TDN requirements. After calving, cows were placed on annual ryegrass pasture and managed similarly at each location. Weight and BCS at calving were greater (P < .05) for females with higher BCS at 90 d prepartum (IBCS) and for those assigned to higher energy levels. Calving and calf growth traits were not affected (P > .05) by IBCS, energy level, prepartum changes in BCS and BW, or BCS at calving. Prepartum changes in BCS and BW regulated by varying energy levels had no effect (P > .05) on postpartum reproduction; however, BCS at calving influenced (P < .03) pregnancy rate and days to pregnancy. Cows with BCS 6 and 7 at calving had higher (P < .05) pregnancy rates (87.0 and 90.7%) than those with BCS 4 and 5 (64.9 and 71.4%). Interval to pregnancy for cows with BCS 4 at calving was 10 to 18 d longer (P < .05) than for those with BCS > or = 5.(ABSTRACT TRUNCATED AT 250 WORDS)

Galanin gene expression is increased in the anterior pituitary gland of the human growth hormone-releasing hormone transgenic mouse.

The peptide galanin is synthesized within and secreted from specific cells of the anterior pituitary gland. Previous studies showed that GH-releasing hormone (GHRH) stimulates galanin release from pituitary cells in vitro. In the present study we used human (h) GHRH transgenic mice to examine the effects of high circulating levels of GHRH on pituitary galanin gene expression in vivo. Moreover, the hGHRH transgenic mice develop pituitary tumors and, thus, may be used as a model of estrogen-independent pituitary adenoma formation. We examined male hGHRH transgenic mice and nontransgenic siblings at 2, 4, 6, 8, and 10 months of age. Transgenic mice were identified using the polymerase chain reaction. Body weights and plasma mGH levels were higher in transgenic mice at all ages. Total protein contents in the anterior pituitary glands of transgenic mice were significantly greater at each age. Galanin peptide contents in the anterior pituitary gland of hGHRH mice were normalized for differences in total protein content and were significantly elevated at all ages examined. At 10 months of age, anterior pituitary galanin peptide concentrations were increased 7-fold. Hypothalamic concentrations of galanin peptide were also increased in hGHRH transgenic mice, but were not greater than those in nontransgenic siblings until 4 months of age. In contrast, no significant differences in galanin peptide concentrations of the neurointermediate lobes were evident. Galanin mRNA concentrations in the anterior pituitary of 6-month-old transgenic mice were increased 4-fold. In conclusion, 1) galanin peptide concentrations in the anterior pituitary gland and hypothalamus are increased in hGHRH transgenic mice compared to those in nontransgenic siblings, whereas galanin peptide concentrations in the neurointermediate lobe are not different; 2) pituitary galanin mRNA concentrations are increased 4-fold in 6-month-old transgenic mice; and 3) the development of pituitary hyperplasia is correlated to the increase in galanin mRNA and peptide concentrations.

Absence of a reservoir of Epstein-Barr virus (EBV) in normal tongue epithelium.

We examined human tongue epithelium and serum samples at autopsy for evidence of latent Epstein-Barr virus (EBV) infection. Although clinical serology revealed anti-EBV antibodies in most sera indicating past EBV infection, we found no Epstein-Barr nuclear antigen (EBNA)-coding sequences in tongue tissue by polymerase chain reaction (PCR), or Epstein-Barr-encoded RNA (EBER1) by in situ hybridization. Tongue epithelium does not appear to be a natural reservoir for latent EBV in immunocompetent hosts.

MtTW-10 pituitary tumor cells: galanin gene expression and peptide secretion.

The peptide galanin is synthesized within and secreted from specific cell types of the rat anterior pituitary gland. The small size of the rat anterior pituitary gland is somewhat limiting for studying the regulation of galanin gene expression and peptide synthesis/secretion. We examined the mammotropic rat pituitary tumor MtTW-10 as a possible model system to study galanin. The objectives of this study were to 1) determine if galanin is secreted from MtTW-10 cells in vitro in a regulated manner, 2) characterize the molecular forms of immunoreactive galanin secreted by MtTW-10 cells, and 3) assess whether galanin gene expression in MtTW-10 tumors is regulated by estradiol. MtTW-10 pituitary tumors were transplanted to female Wistar-Furth rats that were implanted with estradiol-filled capsules. Cells were harvested from the MtTW-10 tumors and cultured for 4 days. When examined by electron microscopy, the MtTW-10 cells maintained in culture were irregular in shape with microvilli on their surface and contained numerous large secretory granules. Immunoreactive galanin, PRL, and GH were secreted from the cells in a time-dependent fashion during static incubations. LH, ACTH, and TSH were undetectable in the culture medium. Somatostatin (10 and 100 nM) inhibited galanin, PRL, and GH release in a dose-dependent manner. In contrast, dopamine, TRH, LH-releasing hormone, CRH, and GH-releasing hormone at concentrations of 10-100 nM failed to alter hormone secretion. Only high concentrations of dopamine (1 microM) inhibited the secretion of galanin, PRL, and GH. HPLC fractionation of peptides secreted by MtTW-10 cells cultures showed that approximately 84% of the galanin immunoreactivity coeluted with synthetic rat galanin. In tumor-bearing rats, plasma levels of immunoreactive galanin were 10-fold higher after estradiol treatment than levels in ovariectomized controls. Galanin mRNA levels were increased 20-fold by estradiol in MtTW-10 tumors, as determined by solution hybridization, and peptide levels were elevated nearly 100-fold. We conclude that 1) galanin is secreted from MtTW-10 cells in vitro, and its secretion is inhibited by somatostatin; and 2) estradiol increases galanin gene expression and peptide secretion in MtTW-10 tumors in vivo. These data show that MtTW-10 tumors may be useful to study the regulation of pituitary galanin gene expression, peptide synthesis, and secretion.

Effect of fenbendazole and ivermectin on development of strongylate nematode eggs and larvae in calf feces.

Thirty-nine weaned steer calves (mean weight 284 kg) were maintained under dry-lot conditions and assigned (based on fecal nematode egg count) to one of three treatment groups of 13 animals each as follows: control (no treatment), fenbendazole (5 mg kg-1), and ivermectin (0.2 mg kg-1). Fecal samples were collected 12 h before treatment, at treatment, and 12, 24, 48 and 72 h after treatment for determination of nematode eggs per gram, and (after culture) infective larvae per gram and population distribution. The effect of treatment on egg development was observed in feces collected 12 and 24 h after treatment. There was essentially no difference in efficacy, based on egg counts, of fenbendazole and ivermectin. Egg count was reduced 100% by both anthelmintics at 72 h after treatment. Viability, based on percent of eggs reaching the infective larval stage, of developing stages at 12, 24, and 48 h after fenbendazole treatment was 0.1%, 1.1%, and 0%; after ivermectin treatment the corresponding values were 23.7%, 30.1%, and 28.6%, respectively. Fenbendazole treatment resulted in little or no development of eggs and/or larvae in feces deposited 12 and 24 h after treatment, whereas development proceeded normally (compared with the control group) in ivermectin treated feces. Population distribution of infective larvae was predominantly Haemonchus and Cooperia with some Ostertagia and Oesophagostomum.

Postweaning growth and reproduction of beef heifers exposed to calve at 24 or 30 months of age in spring and fall seasons.

Angus and Angus x Hereford heifer calves born in spring or fall seasons were allotted by weight at weaning to be exposed to bulls for calving at either 24 or 30 mo of age. Comparisons were made 1) within birth season--heifers born in the same season were first exposed to bulls at either 14 to 16 or 19 to 22 mo of age and 2) within breeding season--heifers born in different but consecutive seasons (spring-fall or fall-spring) were exposed to bulls during the same season but at different ages. Spring-born heifers exposed for 30-mo calving were heavier (336 vs 302 kg) and taller (P less than .01) at breeding than those exposed for 24-mo calving. Also, more were observed in estrus and became pregnant (P less than .01) during a 21-d AI breeding period, but season-long (63 d) pregnancy rates were not different (86%). Fall-born heifers exposed for 24- or 30-mo calving were similar for weight, hip height, and body condition score (BCS) at breeding, but season-long pregnancy rates were 71 and 94%, respectively (P less than .01). Although fall-born heifers were heavier at weaning (P less than .01), spring-born heifers were heavier, taller, and had higher BCS at breeding (P less than .01), regardless of age. Within spring breeding seasons, breeding weight and initial reproduction were not affected by heifer age. Within fall breeding seasons, older heifers were larger (P less than .01) and had greater reproductive performance (P less than .05) than younger heifers. Age at breeding, irrespective of season, consistently affected (P less than .01) both hip height (116 vs 113 cm) and pelvic area (209 vs 178 cm2) for older vs younger heifers, respectively. These data indicate that heifers exposed for 30-mo first calving are heavier, taller, have larger pelvic area, and have greater reproductive performance than those exposed for 24-mo first calving.

Distribution of selenium-binding proteins in different tissues of the mouse and rat.

The distribution of selenium-binding proteins in specific tissues of mice and rats was examined by electrophoretic and immunologic techniques. Major selenium-binding proteins of 58K and 26K daltons were present in whole blood, erythrocytes, liver, duodenum, mammary tumors, kidney, testis, ovary and pancreas by electrophoretic analysis. By Western immunoblot it was evident that the 58K protein in plasma did not cross-react with the cellular 58 K protein. Furthermore, muscle did not exhibit any immunologically recognizable 58K protein. The antibody raised against mouse liver 58K recognized a similar protein in rat liver, kidney and testis. The 58K selenium-binding protein appeared to be concentrated in tissues enriched in G1 and the effect of hydroxyurea on selenium-binding protein levels suggested the 58K selenium-binding protein appeared to be made predominantly during the G1 phase of the cell cycle. Evidence is also presented that whole blood contains selenium bound to hemoglobin which supports prior evidence by other investigators. These results further support the evidence for tissue selenium-binding proteins other than glutathione peroxidase and document the immunological specificity and reactivity of a new antibody against a selenium-binding protein.

Growth and sexual characteristics of suckling beef calves as influenced by age at castration and growth implants.

A 2-yr study using crossbred male calves (n = 228) evaluated castrating at birth or at 4 mo of age and use of anabolic growth implants (none, zeranol or estradiol-17 beta). Angus, Hereford and Brahman crossbred calves produced in seven cow-calf units that varied by breed component, stocking rate and calving season were allotted to treatment at birth in a 2 x 3 factorial arrangement. Growth implants decreased (P less than .01) testicular weight and expression (P less than .05) of male secondary sex characteristics in suckling bull calves at 4 mo. Implanted calves were shorter (P less than .05) at the hips and had shorter front legs (P less than .01) at both 4 mo and at weaning. Cannon bone circumference at weaning was increased (P less than .05) by growth implants. Age at castration did not affect (P greater than .05) calf performance or body characteristics. Calves given growth implants had higher (P less than .05) rates of gain from birth to 4 mo than did nonimplanted calves (.75 vs .71 kg/d). Implanted calves were heavier (P less than .01) at weaning and had higher (P less than .01) ADG from 4 mo to weaning than did nonimplanted calves. These data indicate no benefit from delaying age at castration, but implanting increased weaning weight an average of 8.2 kg.

Time course of selenite metabolism in confluent cultures of mouse mammary epithelial cells.

The distribution of 75Se selenite in various macromolecules over time was evaluated in confluent cultures of the LMA mouse mammary epithelial cell line. 75Se label did not distribute equally to all fractions at the same time point. The label initially entered the selenonucleic acid fraction and subsequently increasing quantities were detected in the selenoprotein fraction. The time period of increasing inhibition of DNA synthesis correlated with increasing levels of selenoproteins. The major selenoprotein found in this time frame in confluent phase LMA cells was an acidic, 58K selenoprotein.

Selenite distribution in log and confluent growth phase murine mammary epithelial cells.

Two highly selenite sensitive cell lines with different growth rates were used to evaluate the effect of cell growth phase on selenite retention, selenite distribution, selenite inhibition of DNA synthesis and presence of selenoproteins. Autoradiography of log and confluent phase MOD cells revealed a uniform retention of selenite in log phase cells and a marked lack of uniformity of selenite retention in confluent phase cells. A higher total percentage of selenite was retained and covalently incorporated into proteins by confluent phase cells. Levels of the 58K selenoprotein, but not the 26K and 23K selenoproteins, were higher in confluent versus log phase cells. The results suggest that the 58K selenoprotein accumulated in cell populations where DNA synthesis was inhibited in contrast to cells actively undergoing cell proliferation. In addition, the 58K selenoprotein was the only major selenoprotein present in both log and confluent phase cells during and before inhibition of DNA synthesis. The implications of these results are discussed in terms of potential combination chemoprevention protocols in animal tumor experiments.